Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06521372 · ClinicalTrials.gov registry record
The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF
A clinical trial of Infertility Primary, sponsored by Ovation Fertility.
- Recruiting
- Registry status
- 450
- Enrollment target
- 3
- Study locations
NCT06521372 is a study of Infertility Primary that is actively recruiting participants, run by Ovation Fertility. The registered enrollment target is 450 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT06521372, a study of Infertility Primary, is actively recruiting participants, sponsored by Ovation Fertility.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 3
- Study locations
Study Summary
The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.
Conditions Studied
Interventions
- OTHER Magenta AI image analysis tool
Study Locations (3)
Nevada
- Ovation Fertility Las Vegas - Las Vegas
Ohio
- Ovation Fertility Cincinnati - Cincinnati
Tennessee
- Ovation Fertility - Nashville - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2027-01-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06521372
The ClinicalTrials.gov registry entry for NCT06521372 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ovation Fertility, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertility Primary appearing as the primary indexed condition, and to 1 intervention - of which Magenta AI image analysis tool is the first listed.
NCT06521372 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Nevada, Ohio, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06521372 about?
NCT06521372 is a clinical study titled "The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF". The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.
What is the current status of trial NCT06521372?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2024-01-01. Estimated completion is 2027-01-02.
What conditions does trial NCT06521372 study?
This clinical trial studies the following conditions: Infertility Primary.
What interventions are being tested in trial NCT06521372?
The interventions under investigation include: Magenta AI image analysis tool (OTHER).
Who is sponsoring clinical trial NCT06521372?
This trial is sponsored by Ovation Fertility, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06521372 being conducted?
This trial has 3 study locations across Nevada, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility Primary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.